AzTrials
AzTrials

Amyotrophic Lateral SclerosisBCI-FITNCT04468919

Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit

A study testing BCI-FIT multi-modal access, BCI-FIT adaptive signal modeling and BCI-FIT active querying in people with Amyotrophic Lateral Sclerosis and Brainstem Stroke, run by Oregon Health and Science University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This project adds to non-invasive BCIs for communication for adults with severe speech and physical impairments due to neurodegenerative diseases. Researchers will optimize \& adapt BCI signal acquisition, signal processing, natural language processing, \& clinical implementation. Read more about this study

Who is it for?
Ages 18 to 89 yearsHealthy volunteers can take part
What is being tested?
BCI-FIT multi-modal access, BCI-FIT adaptive signal modeling and BCI-FIT active querying
Could I receive a placebo?
No, everyone receives an active treatment
How many people
55 participants
Where
1 siteUnited States
Study dates
15 Jul 2022to 5 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 89 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Controls
  • Able to read and communicate in English
  • Capable of participating in study visits lasting 1-3 hours
  • Adequate visuospatial skills to select letters, words, or icons to copy or generate messages
  • Live within a 2-hour drive of OHSU or is willing to travel to OHSU
  • Participants with severe speech and physical impairment:
Show all 13Show fewer
  • Adults between 18-89 years of age
  • SSPI that may result from a variety of degenerative or neurodevelopmental conditions, including but not limited to: Duchenne muscular dystrophy, Rett Syndrome, ALS, brainstem CVA, SCI, and Parkinson-plus disorders (MSA, PSP)
  • Able to read and communicate in English with speech or AAC device
  • Capable of participating in study visits lasting 1-3 hours
  • Adequate visuospatial skills to select letters, words or icons to copy or generate basic messages
  • Life expectancy greater than 6 months
  • Able to give informed consent or assent according to IRB approved policy

Who cannot join

  • Participants with severe speech and physical impairment:
  • Unstable medical conditions (fluctuating health status resulting in multiple hospitalizations within a 6 week interval)
  • Unable to tolerate weekly data collection visits
  • Photosensitive seizure disorder
  • Presence of implanted hydrocephalus shunt, cochlear implant or deep brain stimulator
  • High risk of skin breakdown from contact with data acquisition hardware.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Oregon Health & Science University

    Portland, Oregon, 97239

Other trials in United States

About this study

This project adds to non-invasive BCIs for communication for adults with severe speech and physical impairments due to neurodegenerative diseases. Researchers will optimize \& adapt BCI signal acquisition, signal processing, natural language processing, \& clinical implementation. BCI-FIT relies on active inference and transfer learning to customize a completely adaptive intent estimation classifier to each user's multi-modality signals simultaneously. 3 specific aims are: 1. develop \& evaluate methods for on-line \& robust adaptation of multi-modal signal models to infer user intent; 2. develop \& evaluate methods for efficient user intent inference through active querying, and 3. integrate partner \& environment-supported language interaction \& letter/word supplementation as input modality. The same 4 dependent variables are measured in each SA: typing speed, typing accuracy, information transfer rate (ITR), \& user experience (UX) feedback. Four alternating-treatments single case experimental research designs will test hypotheses about optimizing user performance and technology performance for each aim.Tasks include copy-spelling with BCI-FIT to explore the effects of multi-modal access method configurations (SA1.3a), adaptive signal modeling (SA1.3b), \& active querying (SA2.2), and story retell to examine the effects of language model enhancements. Five people with SSPI will be recruited for each study. Control participants will be recruited for experiments in SA2.2 and SA3.4. Study hypotheses are: (SA1.3a) A customized BCI-FIT configuration based on multi-modal input will improve typing accuracy on a copy-spelling task compared to the standard P300 matrix speller. (SA1.3b) Adaptive signal modeling will allow people with SSPI to typing accurately during a copy-spelling task with BCI-FIT without training a new model before each use. (SA2.2) Either of two methods of adaptive querying will improve BCI-FIT typing accuracy for users with mediocre AUC scores. (SA3.4) Language model enhancements, including a combination of partner and environmental input and word completion during typing, will improve typing performance with BCI-FIT, as measured by ITR during a story-retell task. Optimized recommendations for a multi-modal BCI for each end user will be established, based on an innovative combination of clinical expertise, user feedback, customized multi-modal sensor fusion, and reinforcement learning.

Read the detailed description

For each specific aim, the development of new assistive technology BCI access methods will be evaluated in one or more experiments using alternating-treatments single-case research design (SCRD) with healthy controls and/or participants with SSPI. SCRD is ideal for examining small, heterogenous populations such as individuals with SSPI. It allows for detailed examination of performance trends and changes over time, and for participant-specific modifications to the intervention as part of an iterative design process. Because each participant serves as their own control, a sample size of five is sufficient to demonstrate and replicate an initial effect. Please see the Statistical Design and Power section for additional information about SCRD and data visualization and analysis.

A total of 60 participants will evaluate the BCI advancements; 15 individuals with SSPI and 45 controls. Participants with SSPI who currently have a reliable means of communication, either using speech and/or an AAC device, will be enrolled. All participants will be within the ages of 18-89 years (NIH-defined adults), with an equal number of men and women. Healthy controls will be matched for age, gender, and education level. In SCRD studies, each participant serves as their own control, so participants will experience all of the baseline and intervention conditions included in each individual study, as described below. Condition order will be randomized in the alternating-treatments, controlled such that each participant completes an equal number of sessions with each intervention, with no more than two consecutive sessions with the same intervention. Blinding is not possible as each subject must know their condition in an alternating treatment design.

All study visits with people with SSPI will be conducted in participants' homes by OHSU staff. Study visits with healthy controls will take place at the OHSU BCI laboratory. For all typing tasks, participants are seated approximately 75cm from an LCD display, set up for the BCI-FIT system. Depending on the user's customized BCI-FIT configuration (procedures described in SA1.1), one or more of the following control signals will be used in each typing session: EEG (ERP, Code or SSVEP), eye movements (gaze position or velocity), or binary switches. The experiments for SA1.3a, SA1.3b, and SA2.2 all involve copy-spelling tasks, in which participants will copy five common 5-letter English words of approximately equal typing difficulty (according to LM input), and correct mistakes by choosing the backspace character when appropriate. Individual signal models will be initialized to population models and will be personalized and refined with each acquired copy-spelling task data set. The experiment for SA3.4 involves a story-retell task, described below in the paragraph about that experiment.

Experiment 1.3a will test the hypothesis that a customized BCI-FIT configuration based on multi-modal input will improve typing accuracy on a copy-spelling task compared to a standard P300 matrix speller. We will pilot test new multi-modal input features with control participants before every SCRD with participants who present with SSPI. It will include five participants with SSPI in an alternating-treatments SCRD and will concentrate on typing accuracy as the primary DV. An initial baseline phase will involve weekly copy-spelling sessions with each participant's existing access method. Three or more baseline sessions will be conducted until stable performance is observed, then the alternating-treatments phase will begin. Treatments consist of two different BCI-FIT configurations: 1) a multi-modal configuration chosen by a combination of the approaches described in SA1.1. (clinically-supported and performance data-supported) and 2) a standard P300 matrix speller. In weekly data-collection visits, participants will complete copy-spelling sessions with each BCI-FIT configuration, with counterbalanced session order. Participants complete at least five sessions with each configuration, more if needed to achieve stable performance.

In Experiment 1.3b, it is hypothesized that adaptive individualized signal modeling will allow people with SSPI to type accurately during a copy-spelling task with BCI-FIT without training a new model for each use. This experiment will also include five participants with SSPI in an alternating-treatments SCRD with typing accuracy as the primary DV. In this study, no baseline is planned, as the comparison of interest is between versions of BCI-FIT with and without adaptive signal modeling. Initially, each participant will complete system optimization procedures described in SA1.1 and SA1.2 to identify their customized BCI-FIT configuration. During each visit, in the alternative treatments experiment, the participant will attempt three copy-spelling sessions with their customized BCI-FIT configuration, using three different model types: (1) a single calibration completed by the same user immediately before copy spelling; (2) multiple calibrations completed by the same user on previous days; (3) multiple calibrations completed by other users. Data will be graphed and analyzed separately (following procedures in the Statistical Design and Power section) to evaluate effects on performance with both system versions.

The experiment in SA2.2 will test the hypothesis that either of two methods of adaptive querying will improve BCI-FIT typing accuracy for users with mediocre AUC scores. It will include five controls and five participants with SSPI, each with an AUC score in the range of 70-80%. (Based on pilot testing, adaptive querying is expected to provide the most benefit to users with this level of baseline performance.) The experiment will follow an alternating-treatments SCRD. In the baseline phase, participants will complete weekly copy-spelling sessions with BCI-FIT without adaptive querying. Each weekly visit will include two copy-spelling sessions with BCI-FIT either with or without adaptive querying techniques. Condition order will be counterbalanced such that conditions occur in random order (with no more than two instances of the same condition in a row) and participants will experience each condition an equal number of times (at least five times each, until stable performance is achieved).

The experiment in SA3.4 will use an alternating-treatments SCRD experiment to test the hypothesis that language model enhancements, including a combination of partner and environmental input and word completion during typing, will improve typing performance with BCI-FIT, as measured by ITR during a story-retell task. This experiment will include five controls and five participants with SSPI, each paired with a partner to provide partner input (total enrollment of 10 dyads). In each weekly data-collection visit, participants will engage in two structured story-retell activities, one with and one without the enhanced language model features. Condition order will be counterbalanced such that conditions occur in random order (with no more than two instances of the same condition in a row) and participants will experience each condition an equal number of times (at least five times each, until stable performance is achieved). The story-retell activity will involve the participant watching a short video along with a communication partner, then using BCI-FIT to answer questions posed by a third person. The primary DV in this experiment will be ITR.

Being tested
BCI-FIT multi-modal access, BCI-FIT adaptive signal modeling, BCI-FIT active querying, BCI-FIT language modeling
Keywords
brain-computer interface
Medical subject headings
Amyotrophic Lateral Sclerosis, Brain Stem Infarctions, Muscular Dystrophies, Parkinson Disease, Parkinsonian Disorders, Multiple System Atrophy, Spinal Cord Injuries, Locked-In Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BCI-FIT multi-modal accessBehavioural

    Adding a personalized multi-modal access protocol to customize a BCI-FIT access method configuration for each individual end user, based on a combination of user characteristics, clinical expertise, user feedback, and system performance data in the software.

  • BCI-FIT adaptive signal modelingBehavioural

    Adding a BCI-FIT adaptive signal modeling that employs transfer learning and on-line model adaptation techniques with noisy labels in the software of this brain-computer interface to eliminate the need for data collection exclusively for model calibration, as well as to address model drift issues associated with drowsiness, fatigue, and other human and environmental factors.

  • BCI-FIT active queryingBehavioural

    Adding BCI-FIT active querying techniques which are software-based optimal action control policies in the brain-computer interface developed with active and reinforcement learning techniques in order to perform efficient user intent inference to improve the entire speed-accuracy trade-off curve for alternative communication.

  • BCI-FIT language modelingBehavioural

    Adding vocabulary and location information (called partner and environmental input) to the language models in the brain-computer interface from a user's communication partner.

Study groups in NCT04468919
Study groupRoleWhat they receive
BCI-FIT multi-modal configurationExperimentalFor this single case research design with alternating treatments without baseline, 5 participants with severe speech and physical impairment will complete copy spelling tasks with a standard P300 matrix speller layout and with the multi-modal configurations optimized from the BCI-FIT algorithms. Outcome measures are typing accuracy, typing speed and user experience.
Receives: Behavioral: BCI-FIT multi-modal access
Adaptive signal modelingExperimentalFor this single case research design with alternating treatments without baseline, 5 participants with severe speech and physical impairment will complete copy spelling tasks with 3 signal adaptive modeling configurations. Outcome measures are typing accuracy, typing speed and user experience.
Receives: Behavioral: BCI-FIT adaptive signal modeling
Active querying techniquesExperimentalFor this single case research design with alternating treatments without baseline, 5 control volunteers and 5 participants with severe speech and physical impairment who have AUC scores between 70-80% will complete copy spelling tasks with BCI-FIT active querying technique on and with BCI-FIT active querying technique off. Outcome measures are typing accuracy, typing speed and user experience.
Receives: Behavioral: BCI-FIT active querying
Language modelingExperimentalFor this single case research design with alternating treatments, 5 control volunteers and 5 participants with severe speech and physical impairment, each with a control partner for partner input will complete a story retell task with BCI-FIT language modeling features on and with BCI-FIT language modeling features off. Outcome measures are information transfer rate and user experience.
Receives: Behavioral: BCI-FIT language modeling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Typing Accuracy

    Correct character selections divided by the total character selections in a copy spelling task.

    Measured: 12 data collection sessions over 12 weeks (1 session/week) to assess change

  2. Typing Speed

    Correct character selections per minute in a copy spelling task.

    Measured: 12 data collection sessions over 12 weeks (1 session/week) to assess change

  3. Information transfer rate

    Time-averaged mutual information between intended and typed symbols from the alphabet, computed using probability distributions in accordance with a language model

    Measured: 12 data collection sessions over 12 weeks (1 session/week) to assess change

  4. User experience

    Responses to 10 items on the NASA TLX questionnaire about comfort, workload and satisfaction using the brain-computer interface system during all typing tasks

    Measured: 12 data collection sessions over 12 weeks (1 session/week) to assess change

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jul 2020
  2. Study start15 Jul 2022
  3. Primary completion5 May 2025
  4. Study completion5 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Sequential
Model description
Single case research design with: Alternating treatments without baseline for experiments 1.3a, 2.2; Alternating treatments without baseline for experiments 1.3b and 3.4
Masking
None (open label)
Enrolment
55 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04468919
Sponsor's protocol ID
STUDY00015331
Acronym
BCI-FIT
Status last verified
Mar 2025
First submitted
8 Jul 2020
Last updated
16 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Three types of information will be available to other researchers. 1. The Python code (called BciPy) that runs the BCI-FIT system is open sourced and available to other laboratories that are building and implementing non-invasive brain-computer interfaces. 2. The datasets of neurophysiological data (EEG, EOG, EMG) collected during use of BciPy in different experimental configurations will be made available. All data are de-identified and maintained in an OHSU-secure BOX folder, an OHSU REDCap database and OHSU approved and compliant human subjects research repository. 3. The typing speed, typing accuracy and user experience data from the four single case research studies will be de-identified and stored in an OHSU REDCap database and OHSU approved and compliant human subjects research repository.

Publications

  • Peters B, Celik B, Gaines D, Galvin-McLaughlin D, Imbiriba T, Kinsella M, Klee D, Lawhead M, Memmott T, Smedemark-Margulies N, Wiedrick J, Erdogmus D, Oken B, Vertanen K, Fried-Oken M. RSVP keyboard with inquiry preview: mixed performance and user experience with an adaptive, multimodal typing interface combining EEG and switch input. J Neural Eng. 2025 Feb 4;22(1):10.1088/1741-2552/ada8e0. doi: 10.1088/1741-2552/ada8e0.

    PubMed 39793200

Questions about this trial

What is this clinical trial studying?

A study testing BCI-FIT multi-modal access, BCI-FIT adaptive signal modeling and BCI-FIT active querying in people with Amyotrophic Lateral Sclerosis and Brainstem Stroke, run by Oregon Health and Science University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Typing Accuracy (time frame: 12 data collection sessions over 12 weeks (1 session/week) to assess change). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04468919, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in